Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · IEX Real-Time Price · USD

109.94

+0.67 (0.61%)

At close: Apr 19, 2024, 4:00 PM

110.35

+0.41 (0.37%)

After-hours: Apr 19, 2024, 6:59 PM EDT

Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2005
Cash & Equivalents	1,506	881.48	591.45	1,058	637.34	309.62	386.04	365.96	988.79	684.04	Upgrade
Short-Term Investments	120	0	0	1,075	440	515	215	60	0	0	Upgrade
Cash & Cash Equivalents	1,626	881.48	591.45	2,133	1,077	824.62	601.04	425.96	988.79	684.04	Upgrade
Cash Growth	84.50%	49.04%	-72.27%	97.97%	30.65%	37.20%	41.10%	-56.92%	44.55%	7.47%	Upgrade
Receivables	705.79	651.49	563.36	396.49	355.99	263.84	224.13	234.24	209.69	186.37	Upgrade
Inventory	597.04	714.06	1,073	95.4	78.61	52.96	43.25	34.05	19.45	30.04	Upgrade
Other Current Assets	506.29	359.1	383.81	214.91	118.33	92.59	99.87	53.81	39.75	115.4	Upgrade
Total Current Assets	3,435	2,606	2,611	2,840	1,630	1,234	968.28	748.07	1,258	1,016	Upgrade
Property, Plant & Equipment	234.99	301.38	343.42	257.1	270.89	200.36	170.08	107.49	85.57	58.36	Upgrade
Goodwill and Intangibles	7,171	7,487	8,980	3,153	3,361	3,659	3,927	3,906	1,843	2,140	Upgrade
Other Long-Term Assets	551.78	440.64	363.95	285.88	276.74	110.16	58.65	38.86	146.63	124.6	Upgrade
Total Long-Term Assets	7,958	8,229	9,687	3,696	3,909	3,969	4,155	4,052	2,075	2,323	Upgrade
Total Assets	11,393	10,835	12,299	6,536	5,539	5,203	5,124	4,800	3,333	3,339	Upgrade
Accounts Payable	102.75	90.76	100.3	26.95	45.73	40.6	24.37	22.42	21.81	25.13	Upgrade
Deferred Revenue	0	0.46	2.56	4.86	9.58	15	24.73	3.72	5.09	5.64	Upgrade
Current Debt	604.95	31	31	246.32	33.39	33.39	40.61	36.09	37.59	9.43	Upgrade
Other Current Liabilities	828.99	810.97	675.45	375.62	275.79	256.5	204.24	195.17	162.16	176.61	Upgrade
Total Current Liabilities	1,537	933.19	809.3	653.75	364.49	345.49	293.95	257.41	226.64	216.8	Upgrade
Long-Term Debt	5,167	5,765	6,106	1,989	1,725	1,563	1,540	1,994	1,151	1,333	Upgrade
Other Long-Term Liabilities	952.46	1,051	1,418	233.86	338.33	537.56	576.2	671.95	356.47	417.95	Upgrade
Total Long-Term Liabilities	6,120	6,816	7,524	2,222	2,063	2,101	2,117	2,665	1,507	1,751	Upgrade
Total Liabilities	7,656	7,750	8,333	2,876	2,428	2,446	2,411	2,923	1,734	1,968	Upgrade
Total Debt	5,772	5,796	6,137	2,235	1,758	1,596	1,581	2,030	1,188	1,342	Upgrade
Debt Growth	-0.41%	-5.56%	174.61%	27.09%	10.15%	0.97%	-22.10%	70.78%	-11.47%	144.09%	Upgrade
Retained Earnings	878.66	733.59	830.23	1,160	1,068	841.05	917.96	528.91	302.69	34.7	Upgrade
Comprehensive Income	-842.15	-1,125.51	-400.36	-134.35	-223.39	-197.79	-140.88	-317.33	-267.47	-122.1	Upgrade
Shareholders' Equity	3,737	3,086	3,965	3,660	3,111	2,757	2,713	1,877	1,599	1,371	Upgrade
Net Cash / Debt	-4,145.86	-4,914.7	-5,545.7	-102.1	-681.14	-771.79	-980	-1,603.66	-199.66	-658.39	Upgrade
Net Cash Per Share	-57.53	-78.59	-92.90	-1.81	-11.84	-12.61	-15.98	-25.92	-3.17	-10.51	Upgrade
Working Capital	1,899	1,673	1,802	2,186	1,266	888.52	674.33	490.66	1,031	799.04	Upgrade
Book Value Per Share	59.05	49.34	66.42	65.69	54.82	45.98	45.20	31.03	26.11	22.95	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).